Zobrazeno 1 - 10
of 183
pro vyhledávání: '"D, Lellouche"'
Publikováno v:
Pacing and Clinical Electrophysiology. 23:1801-1803
UNLABELLED Evaluation of the quality of atrial sensing is indispensable to monitor the performance of VDD single-lead systems. In addition to counters, a new VDD system offers storage of intracardiac electrograms (EGMs). The clinical contribution of
Autor:
C W, Israel, J B, Böckenförde, B, Nowak, W, Hartung, D, Gascon, G, Campanale, D, Lellouche, P, Pascotto, A S, Manolis, J G, Martinez, A J, Timmermans, P, Blanc
Publikováno v:
HerzschrittmachertherapieElektrophysiologie. 11
Publikováno v:
European Heart Journal. 11:43-47
Thrombolytic treatment efficacy is greater when the delay between onset of pain and treatment is short. One way to shorten this delay is to give treatment at home, but one cannot recommend this technique if it has not been demonstrated first, that pr
Autor:
D. Lellouche, W. M. Hartung, Carsten W. Israel, P. Pascotto, P. Blanc, Antonis S. Manolis, D. Gascon, Bernd Nowak, M. Knops, G. Campanale, J. G. Martinez, A. J. M. Timmermans
Publikováno v:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 4(2)
AIM The purpose of this study was to evaluate the performance of a new VDD pacing system incorporating a high impedance, single-pass VDD lead. The new lead is a bipolar, steroid-eluting, high impedance lead with a full-ring atrial dipole. METHODS AND
Publikováno v:
Presse medicale (Paris, France : 1983). 30(17)
The incidence of sudden death remains high. The basic causes are related to ischemic heart disease and heart failure. Automatic defibrillation is the best treatment, as first conceived and implanted by Mirovski twenty years ago. MARKERS OF RISK OF SU
Publikováno v:
Presse medicale (Paris, France : 1983). 30(17)
Several studies have demonstrated that implantable defibrillators improve survival in patients with a very high risk of sudden death. INDICATIONS FOR PRIMARY PREVENTION: The most obvious indication is for young patients with severe recurrent rhythm d
Autor:
D, Lellouche, M, Nourredine, A M, Duval, P, Pujadas, O, Gartenlaub, A, Castaigne, J C, Cachin, P, Guéret
Publikováno v:
Archives des maladies du coeur et des vaisseaux. 92(12)
The authors report their experience with dual-chamber pacing in hypertrophy obstructive cardiomyopathy. 22 patients (14 women and 8 men) mean age 60 +/- 13 years were implanted between 1992 and 1998. The criteria for pace-maker implantation were the
Autor:
D. Lellouche, J.-P. Darmon, F.-X. Soto, F. Quennelle, C. Pelade, J.-P. Camous, L Fauchier, Dominique Babuty, Florent Briand, Thomas Lavergne, J. Levy, Philippe Poret
Publikováno v:
EP Europace. 4:B8-B9
Publikováno v:
European heart journal. 15(10)
We report a case of an almost permanent ventricular tachycardia that occurred in a 39-year-old man a few weeks before admission to the hospital. This arrhythmia was noticeable by its total irregularity and its association with a left ventricular dysf
Publikováno v:
Intensive care medicine. 20(5)
To assess the effects of piroximone, a phosphodiesterase inhibitor, on right ventricular function in patients with heart failure.Randomized study: patients were randomly assigned to the piroximone infusion rate of 5 or 10 micrograms/kg/min.Cardiologi